PR Newswire Asia's news > Medical/Pharmaceuticals

 |   Detail   |   Print    Next page > 
     
Datasea's Five AI Agent Customer Arrangements Reach Approximately US$4.0 Million in Aggregate Service Value
2026-10-13T    Computer Software   Computer/Electronics   Internet Technology   Medical/Pharmaceuticals 
AI-driven Molecular Glue Innovation: Insilico Nominates ISM9546, an Oral, Peripheral-Restricted VAV1 Degrader as PCC for Autoimmune Diseases
2026-10-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ailux Appoints Lloyd S. Miller, M.D., Ph.D., as Chief Medical Officer
2026-10-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech to Present Multiple Study Results at ESMO 2026
2026-10-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China
2026-10-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
The Right Doctor Isn't Always One Doctor
2026-10-13T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases
2026-10-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
World Thrombosis Day campaign urges global action to protect women against blood clots
2026-10-13T    Health Care/Hospital   Medical/Pharmaceuticals 
ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention
2026-10-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration
2026-10-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.